Product
Supplier
Encyclopedia
Inquiry
ATX-304 / O-304 buy - large image1
ATX-304 / O-304 buy - image1
ATX-304 / O-304 buy - image2
ATX-304 / O-304 buy - image3
ATX-304 / O-304 buy - image4

ATX-304 / O-304

GMP FDA COA 73 Inquiries

Unit Price:

$2.5-2.7/G FOB

Get Latest Price
CAS No.:

1261289-04-6

Content:

99.9%

Port:

Shanghai

Packaging:

1KG/BAG

Price valid (until):

2026-12-03

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A
Average Lead Time:
350 days
Qualification:
Main Products:

PEG,Semaglutide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description
    Product Name:O-304

    MF: C16H11Cl2N3O2S
    MW: 380.25

    CAS:  1261289-04-6



    ATX-304 (O-304) is a novel, orally active small-molecule pan-AMPK activator, which is primarily researched for the treatment of metabolic disorders, including type 2 diabetes, obesity, and metabolic syndrome. It achieves hypoglycemic and weight-loss effects by directly activating the AMPK (AMP-activated protein kinase) pathway, synergistically regulating cellular energy metabolism, improving insulin sensitivity, and enhancing glucose uptake in skeletal muscle and adipose tissue.

                                                          ------------------- Company Profile ------------------

    VITALGEN PHARMA CO., LIMITED. is devoted to researching, manufacturing and marketing medical raw materials. The company has established a multi-functional R&D center in Shenzhen Zhongcheng Biomedical Industrial Park, which has a group of innovativedrugs and generic drugs technicians and 60 foreign trade professionals.

    VITALGEN PHARMA CO., LIMITED has built 500 square meters of pilot laboratories, equipped with two sets of 50L glass reactor, four sets of 100L double reactor, six sets of 50L rotary evaporator and matching heating and cooling equipment, to complete the 10kg Pilot complex experiments in complex compounds, a steady cooperation of the amplification plant, from 100kg to the tonnage of the enlarged production.

      medicine has been highly recognized by many well-known enterprises in the industry and has become their main supplier with high-quality products, honest and pragmatic attitude and good customer service. Tianyuan Medicine is dedicated to provide customers both at home and abroad with advanced technology and reasonable price , Quality products and professional technical services.




    Certificates

    Basic Info
    Product Name:

    O-304

    Other Name:

    O-304;O-304 1261289-04-6;4-chloro-N-(2-(4-chlorobenzyl)-3-oxo-2,3-dihydro-1,2,4-thiadiazol-5-yl)benzamide;CS-2682;0 304;O-304;0 304;Benzamide, 4-chloro-N-[2-[(4-chlorophenyl)methyl]-2,3-dihydro-3-oxo-1,2,4-thiadiazol-5-yl]-;O 304,AMPK,O-304,inhibit,Inhibitor,AMP-activated protein kinase,O304

    CAS No.:

    1261289-04-6

    Molecular Formula:

    C16H11Cl2N3O2S

    InChIKeys:

    WEDWLYRQKUTOAX-UHFFFAOYSA-N

    Molecular Weight:

    380.25

    Exact Mass:

    378.995

    EC Number:

    202-303-5

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    92.23

    XLogP3:

    3.9852

    Density:

    1.50±0.1 g/cm3(Predicted)

    PKA:

    7.81±0.20(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    PEG,Semaglutide

    Location:

    1003 SHINGIND BLDG 42-46 TAI LIN PAI RD KWAI CHUNG HONGKONG

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A

    Average lead Time:

    350 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2018

     VITALGEN PHARMA CO., LIMITED is an international leading high-tech enterprise focusing on large-scale biosynthesis of polypeptide drugs. We provide all-round products and services from drug research, clinical development to access to market for global biotechnology and pharmaceutical enterprises.

    We have professional and experienced engineers and scientists, providing new polypeptide drug biosynthesis solutions, which help partners stay ahead of the polypeptide drug discovery, clinical development and market production.
    We have more than 5000 square meters of R&D center and 20000 square meters of intelligent manufacturing base, which can meet the needs of different customers and products, while meeting the GMP conditions for drug production

  • Inquiry History
    73 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    O-304

    100 G Nov 7, 2026
    United States

    ATX-304

    100 MG Nov 4, 2026
    United States

    O-304

    100 G Nov 4, 2026
    Finland

    O-304

    50 G Nov 2, 2026
    United States

    ATX-304

    1  Nov 2, 2026
    United States

    O-304

    50 G Nov 1, 2026
    United States

    O-304

    100 G Oct 31, 2026
    United States

    O-304

    1000 PCS Oct 31, 2026
    Germany

    O-304

    100 G Oct 31, 2026
    United States

    O-304

    1000 G Oct 26, 2026
    United States

    O-304

    200 G Oct 24, 2026
    United States

    O-304

    10 G Oct 24, 2026
    Egypt

    ATX-304

    10 G Oct 24, 2026
    Australia

    O-304

    25 G Oct 23, 2026
    United States

    O-304

    30 G Oct 22, 2026
    Canada

    O-304

    100 G Oct 20, 2026
    United States

    O-304

    50 G Oct 19, 2026
    United States

    O-304

    1 KG Oct 17, 2026
    United States

    O-304

    30 G Oct 15, 2026
    United States

    O-304

    25 G Oct 15, 2026
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.